Gradient high-performance liquid chromatographic method for simultaneous assay of the radiosensitizers etanidazole (SR 2508) and pimonidazole (Ro 03-8799) in biological materials
- 31 December 1987
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 420 (1) , 223-227
- https://doi.org/10.1016/0378-4347(87)80178-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- A phase I study of the combination of two hypoxic cell radiosensitizers, Ro 03-8799 and SR-2508: Toxicity and pharmacokineticsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- A Phase I study of the combined hypoxic cell radiosensitisers, Ro 03–8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrationsThe British Journal of Radiology, 1986
- A clinical phase I toxicity study of Ro 03–8799: plasma, urine, tumour and normal brain pharmacokineticsThe British Journal of Radiology, 1986
- The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrationsInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508International Journal of Radiation Oncology*Biology*Physics, 1984
- High-performance liquid chromatographic analysis of the new hypoxic cell radiosensitiser, Ro 03-8799, in biological samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1978